| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | poly(A) RNA polymerase activity | 6.22e-05 | 12 | 134 | 3 | GO:1990817 | |
| GeneOntologyMolecularFunction | glycogen phosphorylase activity | 1.34e-04 | 3 | 134 | 2 | GO:0008184 | |
| GeneOntologyMolecularFunction | calmodulin binding | 1.65e-04 | 230 | 134 | 8 | GO:0005516 | |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | IP6K3 TENT4A POLR1C OBSCN PKDCC PAPOLB PAK6 BCR TRRAP ZAP70 MST1R PAPOLA FASTK SPHK1 PKM TNKS2 ALK | 1.83e-04 | 938 | 134 | 17 | GO:0016772 |
| GeneOntologyMolecularFunction | intracellularly gated calcium channel activity | 2.24e-04 | 18 | 134 | 3 | GO:0015278 | |
| GeneOntologyMolecularFunction | adenylate cyclase activity | 2.24e-04 | 18 | 134 | 3 | GO:0004016 | |
| GeneOntologyMolecularFunction | ryanodine-sensitive calcium-release channel activity | 2.66e-04 | 4 | 134 | 2 | GO:0005219 | |
| GeneOntologyMolecularFunction | phosphatase binding | 4.17e-04 | 264 | 134 | 8 | GO:0019902 | |
| GeneOntologyMolecularFunction | 1,4-alpha-oligoglucan phosphorylase activity | 4.41e-04 | 5 | 134 | 2 | GO:0004645 | |
| GeneOntologyMolecularFunction | calcium- and calmodulin-responsive adenylate cyclase activity | 4.41e-04 | 5 | 134 | 2 | GO:0008294 | |
| GeneOntologyMolecularFunction | protein tyrosine kinase activity | 4.43e-04 | 145 | 134 | 6 | GO:0004713 | |
| GeneOntologyMolecularFunction | cyclase activity | 5.39e-04 | 24 | 134 | 3 | GO:0009975 | |
| GeneOntologyMolecularFunction | hexosyltransferase activity | 5.63e-04 | 211 | 134 | 7 | GO:0016758 | |
| GeneOntologyMolecularFunction | phosphorus-oxygen lyase activity | 6.10e-04 | 25 | 134 | 3 | GO:0016849 | |
| GeneOntologyMolecularFunction | calcium-induced calcium release activity | 6.59e-04 | 6 | 134 | 2 | GO:0048763 | |
| GeneOntologyMolecularFunction | glycosyltransferase activity | 7.38e-04 | 288 | 134 | 8 | GO:0016757 | |
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 1.16e-03 | 31 | 134 | 3 | GO:0099604 | |
| GeneOntologyMolecularFunction | adenylyltransferase activity | 1.16e-03 | 31 | 134 | 3 | GO:0070566 | |
| GeneOntologyMolecularFunction | intracellularly ligand-gated monoatomic ion channel activity | 1.39e-03 | 33 | 134 | 3 | GO:0005217 | |
| GeneOntologyMolecularFunction | actin binding | MYO1G VPS18 MYO1C ACE NOD2 SPTBN4 SYNE3 PLEKHG3 SSH3 KBTBD13 | 1.48e-03 | 479 | 134 | 10 | GO:0003779 |
| GeneOntologyBiologicalProcess | cAMP metabolic process | 2.00e-05 | 25 | 135 | 4 | GO:0046058 | |
| GeneOntologyBiologicalProcess | cAMP biosynthetic process | 4.35e-05 | 11 | 135 | 3 | GO:0006171 | |
| GeneOntologyBiologicalProcess | cellular response to caffeine | 4.35e-05 | 11 | 135 | 3 | GO:0071313 | |
| GeneOntologyBiologicalProcess | cellular response to organic cyclic compound | VPS18 PDE4D ACE SELENON ADCY1 ADCY2 ADCY5 RYR1 RYR2 ITPR1 NOD2 FGF23 ALK TBX2 | 4.39e-05 | 605 | 135 | 14 | GO:0071407 |
| GeneOntologyBiologicalProcess | protein localization to extracellular region | SREBF1 RAB40A NRROS LYST ADCY5 ITPR1 PTPRN2 PARD6A RAB40AL NECAB3 LRRC8A GNAZ | 9.30e-05 | 490 | 135 | 12 | GO:0071692 |
| GeneOntologyBiologicalProcess | cellular response to purine-containing compound | 9.47e-05 | 14 | 135 | 3 | GO:0071415 | |
| GeneOntologyBiologicalProcess | response to purine-containing compound | 1.13e-04 | 166 | 135 | 7 | GO:0014074 | |
| GeneOntologyBiologicalProcess | release of sequestered calcium ion into cytosol by endoplasmic reticulum | 1.21e-04 | 39 | 135 | 4 | GO:1903514 | |
| GeneOntologyCellularComponent | nuclear envelope | TENT4A SREBF1 RAB40A RYR2 ITPR1 SYNE3 RAB40AL GNAZ TNKS2 TNPO3 DYNC1H1 PML | 3.03e-04 | 560 | 136 | 12 | GO:0005635 |
| GeneOntologyCellularComponent | myofibril | 4.26e-04 | 273 | 136 | 8 | GO:0030016 | |
| GeneOntologyCellularComponent | Z disc | 4.67e-04 | 151 | 136 | 6 | GO:0030018 | |
| GeneOntologyCellularComponent | extrinsic component of cytoplasmic side of plasma membrane | 4.84e-04 | 56 | 136 | 4 | GO:0031234 | |
| GeneOntologyCellularComponent | contractile muscle fiber | 6.33e-04 | 290 | 136 | 8 | GO:0043292 | |
| GeneOntologyCellularComponent | I band | 7.69e-04 | 166 | 136 | 6 | GO:0031674 | |
| Domain | LRR_8 | MFHAS1 TPBGL NRROS LGI4 CNOT6 SLIT2 OPTC SLITRK5 LRRC8A SLITRK6 | 4.36e-07 | 171 | 134 | 10 | PF13855 |
| Domain | LRR_TYP | MFHAS1 TPBGL NRROS LGI4 CNOT6 SLIT2 OPTC SLITRK5 LRRC8A SLITRK6 | 6.00e-07 | 177 | 134 | 10 | SM00369 |
| Domain | Leu-rich_rpt_typical-subtyp | MFHAS1 TPBGL NRROS LGI4 CNOT6 SLIT2 OPTC SLITRK5 LRRC8A SLITRK6 | 6.00e-07 | 177 | 134 | 10 | IPR003591 |
| Domain | LRR | MFHAS1 NRROS LGI4 NOD2 CNOT6 SLIT2 OPTC SLITRK5 LRRC8A SLITRK6 | 1.91e-06 | 201 | 134 | 10 | PS51450 |
| Domain | Leu-rich_rpt | MFHAS1 TPBGL NRROS LGI4 NOD2 CNOT6 SLIT2 OPTC SLITRK5 LRRC8A SLITRK6 | 4.17e-06 | 271 | 134 | 11 | IPR001611 |
| Domain | RIH_assoc-dom | 7.11e-06 | 6 | 134 | 3 | IPR013662 | |
| Domain | Ins145_P3_rec | 7.11e-06 | 6 | 134 | 3 | PF08709 | |
| Domain | RIH_assoc | 7.11e-06 | 6 | 134 | 3 | PF08454 | |
| Domain | RIH_dom | 7.11e-06 | 6 | 134 | 3 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 7.11e-06 | 6 | 134 | 3 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 7.11e-06 | 6 | 134 | 3 | IPR015925 | |
| Domain | - | 7.11e-06 | 6 | 134 | 3 | 1.25.10.30 | |
| Domain | RYDR_ITPR | 7.11e-06 | 6 | 134 | 3 | PF01365 | |
| Domain | AC_N | 1.97e-05 | 8 | 134 | 3 | IPR032628 | |
| Domain | Adcy | 1.97e-05 | 8 | 134 | 3 | IPR030672 | |
| Domain | AC_N | 1.97e-05 | 8 | 134 | 3 | PF16214 | |
| Domain | - | MFHAS1 TPBGL NRROS LGI4 NOD2 CNOT6 SLIT2 OPTC SLITRK5 LRRC8A SLITRK6 | 2.05e-05 | 321 | 134 | 11 | 3.80.10.10 |
| Domain | L_dom-like | MFHAS1 TPBGL NRROS LGI4 NOD2 CNOT6 SLIT2 OPTC SLITRK5 LRRC8A SLITRK6 | 2.50e-05 | 328 | 134 | 11 | IPR032675 |
| Domain | LRR_1 | 2.92e-05 | 219 | 134 | 9 | PF00560 | |
| Domain | MIR | 4.18e-05 | 10 | 134 | 3 | PF02815 | |
| Domain | MIR_motif | 4.18e-05 | 10 | 134 | 3 | IPR016093 | |
| Domain | MIR | 4.18e-05 | 10 | 134 | 3 | PS50919 | |
| Domain | MIR | 4.18e-05 | 10 | 134 | 3 | SM00472 | |
| Domain | HbrB | 5.11e-05 | 2 | 134 | 2 | PF08539 | |
| Domain | Bit61/PRR5 | 5.11e-05 | 2 | 134 | 2 | IPR013745 | |
| Domain | NTP_transf_2 | 5.71e-05 | 11 | 134 | 3 | PF01909 | |
| Domain | Polymerase_NTP_transf_dom | 5.71e-05 | 11 | 134 | 3 | IPR002934 | |
| Domain | - | 1.53e-04 | 3 | 134 | 2 | 3.30.70.590 | |
| Domain | PHOSPHORYLASE | 1.53e-04 | 3 | 134 | 2 | PS00102 | |
| Domain | Glycg_phsphrylas | 1.53e-04 | 3 | 134 | 2 | IPR011833 | |
| Domain | Glyco_trans_35 | 1.53e-04 | 3 | 134 | 2 | IPR000811 | |
| Domain | Ryanodine_rcpt | 1.53e-04 | 3 | 134 | 2 | IPR003032 | |
| Domain | NuclTrfase_I_C | 1.53e-04 | 3 | 134 | 2 | IPR011068 | |
| Domain | Ryanrecept_TM4-6 | 1.53e-04 | 3 | 134 | 2 | IPR009460 | |
| Domain | PAP_central | 1.53e-04 | 3 | 134 | 2 | PF04928 | |
| Domain | PAP_RNA-bind | 1.53e-04 | 3 | 134 | 2 | PF04926 | |
| Domain | PolA_pol_cen_dom | 1.53e-04 | 3 | 134 | 2 | IPR007012 | |
| Domain | PolA_pol_RNA-bd_dom | 1.53e-04 | 3 | 134 | 2 | IPR007010 | |
| Domain | Phosphorylase | 1.53e-04 | 3 | 134 | 2 | PF00343 | |
| Domain | RyR | 1.53e-04 | 3 | 134 | 2 | PF02026 | |
| Domain | RR_TM4-6 | 1.53e-04 | 3 | 134 | 2 | PF06459 | |
| Domain | PolyA_polymerase | 1.53e-04 | 3 | 134 | 2 | IPR014492 | |
| Domain | Ryan_recept | 1.53e-04 | 3 | 134 | 2 | IPR013333 | |
| Domain | A/G_cyclase_CS | 2.28e-04 | 17 | 134 | 3 | IPR018297 | |
| Domain | - | 2.72e-04 | 18 | 134 | 3 | 3.30.70.1230 | |
| Domain | Nucleotide_cyclase | 2.72e-04 | 18 | 134 | 3 | IPR029787 | |
| Domain | Guanylate_cyc | 3.22e-04 | 19 | 134 | 3 | PF00211 | |
| Domain | GUANYLATE_CYCLASE_2 | 3.22e-04 | 19 | 134 | 3 | PS50125 | |
| Domain | A/G_cyclase | 3.22e-04 | 19 | 134 | 3 | IPR001054 | |
| Domain | GUANYLATE_CYCLASE_1 | 3.22e-04 | 19 | 134 | 3 | PS00452 | |
| Domain | CYCc | 3.22e-04 | 19 | 134 | 3 | SM00044 | |
| Domain | Cys-rich_flank_reg_C | 4.76e-04 | 90 | 134 | 5 | IPR000483 | |
| Domain | LRRCT | 4.76e-04 | 90 | 134 | 5 | SM00082 | |
| Domain | Adcy_conserved_dom | 7.52e-04 | 6 | 134 | 2 | IPR009398 | |
| Domain | DUF1053 | 7.52e-04 | 6 | 134 | 2 | PF06327 | |
| Domain | Myosin_TH1 | 1.05e-03 | 7 | 134 | 2 | PF06017 | |
| Domain | Myosin_TH1 | 1.05e-03 | 7 | 134 | 2 | IPR010926 | |
| Domain | TH1 | 1.05e-03 | 7 | 134 | 2 | PS51757 | |
| Domain | DH_1 | 1.09e-03 | 63 | 134 | 4 | PS00741 | |
| Domain | RhoGEF | 1.45e-03 | 68 | 134 | 4 | SM00325 | |
| Domain | LRRCT | 1.54e-03 | 32 | 134 | 3 | PF01463 | |
| Domain | RhoGEF | 1.61e-03 | 70 | 134 | 4 | PF00621 | |
| Domain | DH_2 | 1.61e-03 | 70 | 134 | 4 | PS50010 | |
| Domain | - | 1.70e-03 | 71 | 134 | 4 | 1.20.900.10 | |
| Domain | DH-domain | 1.70e-03 | 71 | 134 | 4 | IPR000219 | |
| Domain | ABC_A | 3.22e-03 | 12 | 134 | 2 | IPR026082 | |
| Domain | AAA | 3.83e-03 | 144 | 134 | 5 | SM00382 | |
| Domain | AAA+_ATPase | 3.83e-03 | 144 | 134 | 5 | IPR003593 | |
| Domain | PH | 3.96e-03 | 278 | 134 | 7 | SM00233 | |
| Domain | PH_DOMAIN | 4.04e-03 | 279 | 134 | 7 | PS50003 | |
| Domain | PH_domain | 4.12e-03 | 280 | 134 | 7 | IPR001849 | |
| Domain | ABC_tran | 4.93e-03 | 48 | 134 | 3 | PF00005 | |
| Domain | ABC_TRANSPORTER_2 | 4.93e-03 | 48 | 134 | 3 | PS50893 | |
| Domain | ABC_TRANSPORTER_1 | 5.23e-03 | 49 | 134 | 3 | PS00211 | |
| Domain | PROTEIN_KINASE_TYR | 5.25e-03 | 97 | 134 | 4 | PS00109 | |
| Domain | Tyr_kinase_AS | 5.25e-03 | 97 | 134 | 4 | IPR008266 | |
| Domain | ABC_transporter-like | 5.53e-03 | 50 | 134 | 3 | IPR003439 | |
| Domain | PH | 6.22e-03 | 229 | 134 | 6 | PF00169 | |
| Domain | WD40_repeat_CS | 6.61e-03 | 164 | 134 | 5 | IPR019775 | |
| Pathway | REACTOME_ADENYLATE_CYCLASE_ACTIVATING_PATHWAY | 5.19e-05 | 10 | 109 | 3 | M19522 | |
| Pathway | REACTOME_ADENYLATE_CYCLASE_ACTIVATING_PATHWAY | 5.19e-05 | 10 | 109 | 3 | MM14668 | |
| Pathway | WP_G_PROTEIN_SIGNALING_PATHWAYS | 6.84e-05 | 90 | 109 | 6 | MM15882 | |
| Pathway | WP_G_PROTEIN_SIGNALING | 7.28e-05 | 91 | 109 | 6 | M39426 | |
| Pathway | REACTOME_G_ALPHA_Z_SIGNALLING_EVENTS | 1.16e-04 | 33 | 109 | 4 | MM15058 | |
| Pathway | WP_CELLTYPE_DEPENDENT_SELECTIVITY_OF_CCK2R_SIGNALING | 1.22e-04 | 13 | 109 | 3 | M39589 | |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 1.43e-04 | 147 | 109 | 7 | MM15854 | |
| Pathway | REACTOME_INTRACELLULAR_SIGNALING_BY_SECOND_MESSENGERS | 1.45e-04 | 252 | 109 | 9 | MM15585 | |
| Pathway | REACTOME_ADENYLATE_CYCLASE_INHIBITORY_PATHWAY | 1.54e-04 | 14 | 109 | 3 | MM14669 | |
| Pathway | REACTOME_ADENYLATE_CYCLASE_INHIBITORY_PATHWAY | 1.54e-04 | 14 | 109 | 3 | M750 | |
| Pathway | REACTOME_INTRACELLULAR_SIGNALING_BY_SECOND_MESSENGERS | 1.54e-04 | 313 | 109 | 10 | M27867 | |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 1.68e-04 | 151 | 109 | 7 | M39329 | |
| Pathway | WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS | 1.90e-04 | 154 | 109 | 7 | MM15974 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EP_NE_ADRB_CAMP_SIGNALING_PATHWAY | 1.91e-04 | 15 | 109 | 3 | M47794 | |
| Pathway | PID_LPA4_PATHWAY | 1.91e-04 | 15 | 109 | 3 | M56 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PTH_PTH1R_PKA_SIGNALING_PATHWAY | 1.91e-04 | 15 | 109 | 3 | M47504 | |
| Pathway | WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS | 2.06e-04 | 156 | 109 | 7 | M39475 | |
| Pathway | KEGG_MEDICUS_REFERENCE_LHCGR_GNAS_PKA_SIGNALING_PATHWAY | 2.34e-04 | 16 | 109 | 3 | M47645 | |
| Pathway | KEGG_MEDICUS_REFERENCE_FSHR_GNAS_PKA_SIGNALING_PATHWAY | 2.34e-04 | 16 | 109 | 3 | M47650 | |
| Pathway | REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB | 2.34e-04 | 16 | 109 | 3 | MM14492 | |
| Pathway | WP_MAJOR_RECEPTORS_TARGETED_BY_EPINEPHRINE_AND_NOREPINEPHRINE | 2.34e-04 | 16 | 109 | 3 | M39849 | |
| Pathway | REACTOME_DAG_AND_IP3_SIGNALING | 2.75e-04 | 41 | 109 | 4 | M512 | |
| Pathway | REACTOME_PKA_ACTIVATION_IN_GLUCAGON_SIGNALLING | 2.83e-04 | 17 | 109 | 3 | M26995 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CX3CR1_GNAI_AC_PKA_SIGNALING_PATHWAY | 2.83e-04 | 17 | 109 | 3 | M47544 | |
| Pathway | REACTOME_ADORA2B_MEDIATED_ANTI_INFLAMMATORY_CYTOKINES_PRODUCTION | 3.31e-04 | 43 | 109 | 4 | M29837 | |
| Pathway | REACTOME_GPER1_SIGNALING | 3.95e-04 | 45 | 109 | 4 | M45008 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 3.98e-04 | 19 | 109 | 3 | M47760 | |
| Pathway | WP_ENVELOPE_PROTEINS_AND_THEIR_POTENTIAL_ROLES_IN_EDMD_PHYSIOPATHOLOGY | 4.30e-04 | 46 | 109 | 4 | M39828 | |
| Pathway | REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB | 4.66e-04 | 20 | 109 | 3 | M759 | |
| Pathway | WP_RETT_SYNDROME | 5.06e-04 | 48 | 109 | 4 | M39759 | |
| Pathway | REACTOME_G_ALPHA_Z_SIGNALLING_EVENTS | 5.06e-04 | 48 | 109 | 4 | M10775 | |
| Pathway | REACTOME_ANTI_INFLAMMATORY_RESPONSE_FAVOURING_LEISHMANIA_PARASITE_INFECTION | 6.00e-04 | 134 | 109 | 6 | M29840 | |
| Pathway | REACTOME_OPIOID_SIGNALLING | 6.57e-04 | 90 | 109 | 5 | M6467 | |
| Pathway | REACTOME_G_PROTEIN_MEDIATED_EVENTS | 7.94e-04 | 54 | 109 | 4 | M26911 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_GNAS_TO_CRHR_PKA_ACTH_SIGNALING_PATHWAY | 8.09e-04 | 24 | 109 | 3 | M47520 | |
| Pathway | WP_PHOSPHODIESTERASES_IN_NEURONAL_FUNCTION | 8.52e-04 | 55 | 109 | 4 | M39763 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCMV_UL33_TO_GNAI_AC_PKA_SIGNALING_PATHWAY | 1.03e-03 | 26 | 109 | 3 | M47553 | |
| Pathway | REACTOME_CA_DEPENDENT_EVENTS | 1.03e-03 | 26 | 109 | 3 | MM14495 | |
| Pathway | KEGG_RNA_DEGRADATION | 1.11e-03 | 59 | 109 | 4 | M963 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CRHR_PKA_ACTH_SIGNALING_PATHWAY | 1.15e-03 | 27 | 109 | 3 | M47518 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_RASD1_TO_CRHR_PKA_ACTH_SIGNALING_PATHWAY | 1.15e-03 | 27 | 109 | 3 | M47519 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GHRHR_PKA_GH_SIGNALING_PATHWAY | 1.28e-03 | 28 | 109 | 3 | M47647 | |
| Pathway | PID_ENDOTHELIN_PATHWAY | 1.42e-03 | 63 | 109 | 4 | M8 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TSH_TG_SIGNALING_PATHWAY | 1.42e-03 | 29 | 109 | 3 | M47627 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_GNAS_TO_ACTH_CORTISOL_SIGNALING_PATHWAY | 1.42e-03 | 29 | 109 | 3 | M47515 | |
| Pathway | KEGG_PURINE_METABOLISM | 1.46e-03 | 159 | 109 | 6 | M14314 | |
| Pathway | REACTOME_INTEGRATION_OF_ENERGY_METABOLISM | 1.49e-03 | 108 | 109 | 5 | M17034 | |
| Pathway | REACTOME_LEISHMANIA_INFECTION | 1.55e-03 | 219 | 109 | 7 | M29836 | |
| Pathway | PID_LYSOPHOSPHOLIPID_PATHWAY | 1.59e-03 | 65 | 109 | 4 | M15 | |
| Pathway | KEGG_MEDICUS_VARIANT_CYP11B1_CYP11B2_FUSION_TO_ACTH_CORTISOL_SIGNALING_PATHWAY | 1.73e-03 | 31 | 109 | 3 | M47507 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | ACACA MFHAS1 OBSCN SREBF1 BCR TRRAP PLEKHG5 LYST ABCA7 RYR1 NOD2 MST1R THADA PWWP2B SYNE3 PSME4 SPHK1 ZMIZ2 PYGB HERC1 GNAZ CHPF TNPO3 DYNC1H1 ABCC10 | 1.26e-12 | 1105 | 136 | 25 | 35748872 |
| Pubmed | Assessment of a polymorphism of SDK1 with hypertension in Japanese Individuals. | 5.26e-09 | 142 | 136 | 9 | 19851296 | |
| Pubmed | Association of genetic variants with hemorrhagic stroke in Japanese individuals. | 5.60e-09 | 143 | 136 | 9 | 20198315 | |
| Pubmed | Intracellular calcium release channel expression during embryogenesis. | 5.85e-08 | 3 | 136 | 3 | 9986730 | |
| Pubmed | MYO1C EARS2 PRSS56 LPCAT4 GCDH WDR37 BCR TRRAP ABCA7 SLIT2 THADA VPS52 PWWP2B LRP2 MMS19 TAF5 PML TBX2 ZNF646 | 7.83e-08 | 1116 | 136 | 19 | 31753913 | |
| Pubmed | Ryanodine receptor calcium release channels: lessons from structure-function studies. | 2.33e-07 | 4 | 136 | 3 | 23413940 | |
| Pubmed | 2.33e-07 | 4 | 136 | 3 | 9607712 | ||
| Pubmed | 2.33e-07 | 4 | 136 | 3 | 19120137 | ||
| Pubmed | Intracellular calcium-release channels: regulators of cell life and death. | 5.82e-07 | 5 | 136 | 3 | 9124414 | |
| Pubmed | 1.16e-06 | 6 | 136 | 3 | 23463619 | ||
| Pubmed | Essential Roles of Intracellular Calcium Release Channels in Muscle, Brain, Metabolism, and Aging. | 1.16e-06 | 6 | 136 | 3 | 25966694 | |
| Pubmed | Mapping of adenylyl cyclase genes type I, II, III, IV, V, and VI in mouse. | 1.16e-06 | 6 | 136 | 3 | 7766992 | |
| Pubmed | Expression and regulation of adenylyl cyclase isoforms in the human adrenal gland. | 1.16e-06 | 6 | 136 | 3 | 11549699 | |
| Pubmed | 1.16e-06 | 6 | 136 | 3 | 20519450 | ||
| Pubmed | IP3Rs are sufficient for dendritic cell Ca2+ signaling in the absence of RyR1. | 1.16e-06 | 6 | 136 | 3 | 16844763 | |
| Pubmed | Large-scale identification of c-MYC-associated proteins using a combined TAP/MudPIT approach. | 1.95e-06 | 211 | 136 | 8 | 17314511 | |
| Pubmed | 2.02e-06 | 7 | 136 | 3 | 11860456 | ||
| Pubmed | 2.02e-06 | 7 | 136 | 3 | 12613887 | ||
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | EMC1 EARS2 POLR1C GCDH TMEM214 SLIT2 THADA VPS52 MGAT2 UGGT2 MMS19 CHPF TNPO3 TARS1 DYNC1H1 | 4.56e-06 | 942 | 136 | 15 | 31073040 |
| Pubmed | 4.83e-06 | 9 | 136 | 3 | 12503609 | ||
| Pubmed | Role of the calcium modulated cyclases in the development of the retinal projections. | 4.83e-06 | 9 | 136 | 3 | 17229090 | |
| Pubmed | Mechanism of human immunodeficiency virus-induced complement expression in astrocytes and neurons. | 6.88e-06 | 10 | 136 | 3 | 11884542 | |
| Pubmed | Purification and characterization of a soluble form of mammalian adenylyl cyclase. | 6.88e-06 | 10 | 136 | 3 | 8663304 | |
| Pubmed | 6.88e-06 | 10 | 136 | 3 | 16615126 | ||
| Pubmed | SATB2 EMC1 EARS2 WDR37 BCR PLEKHG5 CNOT6 PSME4 LRRC8A BOP1 ZNF646 | 8.00e-06 | 529 | 136 | 11 | 14621295 | |
| Pubmed | 9.43e-06 | 11 | 136 | 3 | 10089566 | ||
| Pubmed | 9.43e-06 | 11 | 136 | 3 | 10808179 | ||
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | VPS18 EMC1 ACACA MYO1C POLR1C PAK6 TRRAP AFAP1L1 PYGM BOP1 MMS19 HERC1 TNPO3 TARS1 DYNC1H1 CNTF DNPEP | 1.16e-05 | 1284 | 136 | 17 | 17353931 |
| Pubmed | 1.25e-05 | 12 | 136 | 3 | 10807185 | ||
| Pubmed | Modulation of M2-type pyruvate kinase activity by the cytoplasmic PML tumor suppressor protein. | 1.52e-05 | 2 | 136 | 2 | 18298799 | |
| Pubmed | Regulation of spermatogenesis by testis-specific, cytoplasmic poly(A) polymerase TPAP. | 1.52e-05 | 2 | 136 | 2 | 12471261 | |
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 18164588 | ||
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 29514980 | ||
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 17259277 | ||
| Pubmed | Ryanodine receptor oligomeric interaction: identification of a putative binding region. | 1.52e-05 | 2 | 136 | 2 | 14722100 | |
| Pubmed | Structural and functional interactions within ryanodine receptor. | 1.52e-05 | 2 | 136 | 2 | 26009179 | |
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 12654335 | ||
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 32899693 | ||
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 37947604 | ||
| Pubmed | Interaction of the two cytosolic domains of mammalian adenylyl cyclase. | 1.52e-05 | 2 | 136 | 2 | 8692867 | |
| Pubmed | Nod2 Deficiency Augments Th17 Responses and Exacerbates Autoimmune Arthritis. | 1.52e-05 | 2 | 136 | 2 | 30150283 | |
| Pubmed | Ryanodine receptors in human pancreatic beta cells: localization and effects on insulin secretion. | 1.52e-05 | 2 | 136 | 2 | 15033925 | |
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 17652370 | ||
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 12650930 | ||
| Pubmed | Multiminicore Disease – RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY | 1.52e-05 | 2 | 136 | 2 | 20301467 | |
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 30542613 | ||
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 18713863 | ||
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 15280431 | ||
| Pubmed | Expression of the ryanodine receptor isoforms in immune cells. | 1.52e-05 | 2 | 136 | 2 | 11673493 | |
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 11673462 | ||
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 25130497 | ||
| Pubmed | Crystal structures of wild type and disease mutant forms of the ryanodine receptor SPRY2 domain. | 1.52e-05 | 2 | 136 | 2 | 25370123 | |
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 27430888 | ||
| Pubmed | Thermodynamics of calmodulin binding to cardiac and skeletal muscle ryanodine receptor ion channels. | 1.52e-05 | 2 | 136 | 2 | 18618700 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | PDE4D ACACA POLR1C DPP3 PSME4 PAPOLA PKM PYGB BOP1 MMS19 HERC1 UROD TNPO3 TARS1 DYNC1H1 XRCC6 USP47 DNPEP | 1.57e-05 | 1455 | 136 | 18 | 22863883 |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | EMC1 MAN2B2 PROCR LPCAT4 SREBF1 TMEM214 COLGALT1 SELENON ABCA7 ITPR1 MST1R THADA SLITRK5 LRRC8A UGGT2 CHPF | 1.99e-05 | 1201 | 136 | 16 | 35696571 |
| Pubmed | Isoforms of mammalian adenylyl cyclase: multiplicities of signaling. | 2.06e-05 | 14 | 136 | 3 | 14993377 | |
| Pubmed | Characterization of the interactome of the human MutL homologues MLH1, PMS1, and PMS2. | 2.43e-05 | 87 | 136 | 5 | 17148452 | |
| Pubmed | 2.57e-05 | 15 | 136 | 3 | 18303054 | ||
| Pubmed | 2.57e-05 | 147 | 136 | 6 | 16959763 | ||
| Pubmed | 2.92e-05 | 399 | 136 | 9 | 37536630 | ||
| Pubmed | 3.16e-05 | 16 | 136 | 3 | 17567809 | ||
| Pubmed | 3.82e-05 | 17 | 136 | 3 | 26102480 | ||
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | KDM5B USP13 MYO1C POLR1C DPP3 USP37 BCR TRRAP YLPM1 UGGT2 BOP1 MMS19 TNPO3 USP47 | 4.20e-05 | 1005 | 136 | 14 | 19615732 |
| Pubmed | KDM5B USP13 POLR1C SYNGAP1 SPTBN4 YLPM1 PKM LRP2 NECAB3 UROD TNKS2 CHPF TARS1 DYNC1H1 XRCC6 USP47 | 4.47e-05 | 1285 | 136 | 16 | 35914814 | |
| Pubmed | 4.54e-05 | 3 | 136 | 2 | 18200509 | ||
| Pubmed | Interaction of Gsalpha with the cytosolic domains of mammalian adenylyl cyclase. | 4.54e-05 | 3 | 136 | 2 | 9268375 | |
| Pubmed | 4.54e-05 | 3 | 136 | 2 | 18403125 | ||
| Pubmed | 4.54e-05 | 3 | 136 | 2 | 11086001 | ||
| Pubmed | 4.54e-05 | 3 | 136 | 2 | 7876312 | ||
| Pubmed | 4.54e-05 | 3 | 136 | 2 | 24123915 | ||
| Pubmed | 4.54e-05 | 3 | 136 | 2 | 16213210 | ||
| Pubmed | 4.54e-05 | 3 | 136 | 2 | 23278119 | ||
| Pubmed | [Research on the mechanism of hypoxia promoting the migration of lung adenocarcinoma A549 cells]. | 4.54e-05 | 3 | 136 | 2 | 35634673 | |
| Pubmed | Complex alternative RNA processing generates an unexpected diversity of poly(A) polymerase isoforms. | 4.54e-05 | 3 | 136 | 2 | 8628305 | |
| Pubmed | 4.54e-05 | 3 | 136 | 2 | 22948152 | ||
| Pubmed | 4.54e-05 | 3 | 136 | 2 | 23504261 | ||
| Pubmed | Developmental changes in expression of the three ryanodine receptor mRNAs in the mouse brain. | 4.54e-05 | 3 | 136 | 2 | 10788707 | |
| Pubmed | 4.54e-05 | 3 | 136 | 2 | 26772202 | ||
| Pubmed | Ca(2+)-induced Ca2+ release in myocytes from dyspedic mice lacking the type-1 ryanodine receptor. | 4.54e-05 | 3 | 136 | 2 | 7621815 | |
| Pubmed | 4.54e-05 | 3 | 136 | 2 | 34575972 | ||
| Pubmed | Molecular identification of the ryanodine receptor pore-forming segment. | 4.54e-05 | 3 | 136 | 2 | 10473538 | |
| Pubmed | 4.54e-05 | 3 | 136 | 2 | 14534537 | ||
| Pubmed | 4.54e-05 | 3 | 136 | 2 | 23814019 | ||
| Pubmed | 4.54e-05 | 3 | 136 | 2 | 18434746 | ||
| Pubmed | 4.54e-05 | 3 | 136 | 2 | 12754204 | ||
| Pubmed | SPRY domains in ryanodine receptors (Ca(2+)-release channels). | 4.54e-05 | 3 | 136 | 2 | 9204703 | |
| Pubmed | 4.54e-05 | 3 | 136 | 2 | 21881589 | ||
| Pubmed | Isoform-dependent formation of heteromeric Ca2+ release channels (ryanodine receptors). | 4.54e-05 | 3 | 136 | 2 | 12213830 | |
| Pubmed | 4.54e-05 | 3 | 136 | 2 | 9242641 | ||
| Pubmed | Direct association of the reticulon protein RTN1A with the ryanodine receptor 2 in neurons. | 4.54e-05 | 3 | 136 | 2 | 23454728 | |
| Pubmed | 4.54e-05 | 3 | 136 | 2 | 23223241 | ||
| Pubmed | 4.54e-05 | 3 | 136 | 2 | 25644089 | ||
| Pubmed | 4.54e-05 | 3 | 136 | 2 | 25239916 | ||
| Pubmed | 4.54e-05 | 3 | 136 | 2 | 18643873 | ||
| Pubmed | 4.54e-05 | 3 | 136 | 2 | 11159936 | ||
| Pubmed | Epistatic interaction between FCRL3 and MHC in Spanish patients with IBD. | 4.54e-05 | 3 | 136 | 2 | 17389014 | |
| Pubmed | 4.54e-05 | 3 | 136 | 2 | 7959768 | ||
| Pubmed | The organization of proteins in the human red blood cell membrane. A review. | 4.54e-05 | 3 | 136 | 2 | 4600883 | |
| Pubmed | 4.54e-05 | 3 | 136 | 2 | 7635066 | ||
| Interaction | TOP3B interactions | ACACA MYO1C MFHAS1 OBSCN SREBF1 BCR TRRAP PLEKHG5 LYST ABCA7 RYR1 NOD2 MST1R THADA PWWP2B SYNE3 PSME4 FASTK SPHK1 ZMIZ2 PYGB MMS19 HERC1 GNAZ CHPF TNPO3 DYNC1H1 XRCC6 ABCC10 | 1.11e-07 | 1470 | 135 | 29 | int:TOP3B |
| Interaction | CNPY3 interactions | 7.05e-06 | 196 | 135 | 9 | int:CNPY3 | |
| Cytoband | 14q32.13 | 1.68e-05 | 17 | 136 | 3 | 14q32.13 | |
| Cytoband | 15q22 | 8.78e-05 | 29 | 136 | 3 | 15q22 | |
| Cytoband | 2q35 | 9.32e-05 | 79 | 136 | 4 | 2q35 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q35 | 6.09e-04 | 129 | 136 | 4 | chr2q35 | |
| GeneFamily | Adenylate cyclases|Deafness associated genes | 1.69e-05 | 10 | 96 | 3 | 53 | |
| GeneFamily | Glycogen phosphorylases | 8.34e-05 | 3 | 96 | 2 | 437 | |
| GeneFamily | Ryanodine receptors|Protein phosphatase 1 regulatory subunits | 8.34e-05 | 3 | 96 | 2 | 287 | |
| GeneFamily | Myosins, class I | 7.65e-04 | 8 | 96 | 2 | 1097 | |
| GeneFamily | ATP binding cassette subfamily A | 2.44e-03 | 14 | 96 | 2 | 805 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 2.79e-03 | 181 | 96 | 5 | 694 | |
| GeneFamily | Ubiquitin specific peptidases | 3.28e-03 | 56 | 96 | 3 | 366 | |
| Coexpression | GSE26290_CTRL_VS_AKT_INHIBITOR_TREATED_ANTI_CD3_AND_IL2_STIM_CD8_TCELL_DN | 9.38e-07 | 197 | 136 | 9 | M8133 | |
| ToppCell | COVID-19-Heart-CM_5_(RYR2-)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.07e-07 | 144 | 136 | 7 | f92e03dd784e31a9e5dbd4f4c3a6517ea19210cf | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Fibroblasts|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.51e-07 | 157 | 136 | 7 | f086753b51860e23f1275bd75e8802d2a7d7b70a | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.79e-07 | 171 | 136 | 7 | a4a2c5dc995589fbe3d4ca6ee1df888807e4ae34 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma|TCGA-Brain / Sample_Type by Project: Shred V9 | 1.23e-06 | 177 | 136 | 7 | e8ab340b20cd41554c3841fe980e078e878af35f | |
| ToppCell | COPD-Lymphoid-NK|COPD / Disease state, Lineage and Cell class | 1.84e-06 | 188 | 136 | 7 | c9a227c8e71b69929d43e9afb8306a95c8163778 | |
| ToppCell | droplet-Heart-nan-24m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.12e-06 | 192 | 136 | 7 | f6a4e348406a852ace9fb21db8fbdff539217645 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.12e-06 | 192 | 136 | 7 | 8937a59f6bbe07f671bdabbd3707dc9c17a14cd9 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.12e-06 | 192 | 136 | 7 | e4a7f2673f801b008ca67291db2fb2b9fd2955b8 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.12e-06 | 192 | 136 | 7 | ac1477433704573f95111eee6263b93668d2845e | |
| ToppCell | droplet-Heart-nan-24m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.12e-06 | 192 | 136 | 7 | 1a0c25106ae08eac912a4edd5fc1a3ee776f69c2 | |
| ToppCell | (0)_NK_cells-(0)_NK_FCGR3Apos|(0)_NK_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 2.60e-06 | 198 | 136 | 7 | eba39656c6f699ab297b652ded8cb9727b49593c | |
| ToppCell | Transverse-T_cell-Tfh|Transverse / Region, Cell class and subclass | 2.69e-06 | 199 | 136 | 7 | cbef8f95edf2e86e16c448a76068d7ed8f6b7748 | |
| ToppCell | Transverse-(1)_T_cell-(16)_Tfh|Transverse / shred on region, Cell_type, and subtype | 2.69e-06 | 199 | 136 | 7 | aa31e26d48066f865ca33251a33a28934c0a7a44 | |
| ToppCell | COVID-19-Heart-CM_5_(RYR2-)|Heart / Disease (COVID-19 only), tissue and cell type | 8.24e-06 | 155 | 136 | 6 | d7e26696fd9c0a759524f331243db43059b33ed9 | |
| ToppCell | Substantia_nigra-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Gkn3_(Gkn3)-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 9.84e-06 | 93 | 136 | 5 | 4eca07c288fe15531a685522c61746671c1c87fb | |
| ToppCell | Substantia_nigra-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Gkn3_(Gkn3)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 9.84e-06 | 93 | 136 | 5 | 312291db0fab96952017f9faf2057c28f3719556 | |
| ToppCell | Substantia_nigra-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Gkn3_(Gkn3)--|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 9.84e-06 | 93 | 136 | 5 | 8f65381291fc92b56bf0fc2caac013a54560737b | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.39e-05 | 170 | 136 | 6 | cb1ed6bd409ee1cf11be0d5e7cdcffe2ab220d38 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.39e-05 | 170 | 136 | 6 | da4fb1e186e9bec6bba0b25f2a0e68f9e11c6017 | |
| ToppCell | Adult-Mesenchymal-vascular_smooth_muscle_cell|Adult / Lineage, Cell type, age group and donor | 1.49e-05 | 172 | 136 | 6 | c62cad0f4212d1e9ea1ec3143ad3c4e06aff0ebf | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell|Adult / Lineage, Cell type, age group and donor | 1.54e-05 | 173 | 136 | 6 | a5331721bd9f9a66530dd4ffe28cb3a5a8cad8fc | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.75e-05 | 177 | 136 | 6 | 9edfb50856f5e10672ab194ce0076d6a190e64de | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-skeletal_muscle_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.81e-05 | 178 | 136 | 6 | 69f68eeab11b088fcb1f963c92eff0f1cd0e711a | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.99e-05 | 181 | 136 | 6 | 330d4322f4c4373f706273c1f4e218b59051b7fd | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c11-GNLY|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.99e-05 | 181 | 136 | 6 | 5cecbafc29cc95896e6ccb2c74d9237b9aaece69 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.99e-05 | 181 | 136 | 6 | 3f4d5d79c1286614514b0e8134079d6128a2a23e | |
| ToppCell | E18.5-samps-Endothelial-Mature_fetal_endothelial|E18.5-samps / Age Group, Lineage, Cell class and subclass | 2.05e-05 | 182 | 136 | 6 | 7af3b2029b7f55b923d5a4b764d4292f4ea48599 | |
| ToppCell | E16.5-samps-Endothelial-Immature_fetal_endothelial-Intermediate_Endothelial|E16.5-samps / Age Group, Lineage, Cell class and subclass | 2.05e-05 | 182 | 136 | 6 | fec1caf867b1dc87b24504d895ee1a27df78062e | |
| ToppCell | E18.5-samps-Endothelial|E18.5-samps / Age Group, Lineage, Cell class and subclass | 2.05e-05 | 182 | 136 | 6 | e2d799e6e7526176a6fe6515b8fbe4d83d3a3ea1 | |
| ToppCell | Adult-Mesenchymal-pericyte_cell-D122|Adult / Lineage, Cell type, age group and donor | 2.12e-05 | 183 | 136 | 6 | fc31a43a637423cb3bb9aa184a3a889a0b9aaea6 | |
| ToppCell | Control-T_cells-NK_cells|Control / group, cell type (main and fine annotations) | 2.25e-05 | 185 | 136 | 6 | 755c0998c729f462399f1d5e88adf4bfae31be30 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.32e-05 | 186 | 136 | 6 | 4780af76237d7af2abbe2d8d5530cdf53e3ed0b7 | |
| ToppCell | Adult-Mesenchymal-pericyte_cell|Adult / Lineage, Cell type, age group and donor | 2.39e-05 | 187 | 136 | 6 | 62759efb660179402fb574ce5701c89a2e17bcfe | |
| ToppCell | facs-Heart-LA/RA-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.46e-05 | 188 | 136 | 6 | 90dc0e15798d0b984518ad58c7e416e30aff687a | |
| ToppCell | facs-Heart-LA/RA-3m-Mesenchymal-atrial_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.46e-05 | 188 | 136 | 6 | f63dfd076ced81013918363282ae25cbbd8948ae | |
| ToppCell | facs-Heart-LA/RA-3m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.46e-05 | 188 | 136 | 6 | 0554d542149cef654ff1e5e32dfbffd8990b52bd | |
| ToppCell | COPD-Lymphoid-NK|World / Disease state, Lineage and Cell class | 2.54e-05 | 189 | 136 | 6 | c0ac160fa7e68b92414fb1600abcac8ad1a42232 | |
| ToppCell | facs-Heart-LA/RA-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.54e-05 | 189 | 136 | 6 | a08b2d0fa35ffa510050ecffdc68e1b79bbe1632 | |
| ToppCell | IPF-Lymphoid-NK|IPF / Disease state, Lineage and Cell class | 2.54e-05 | 189 | 136 | 6 | d92e880162450f8d01e4b8784eb625275cb8e03e | |
| ToppCell | Control-Lymphoid-NK|World / Disease state, Lineage and Cell class | 2.54e-05 | 189 | 136 | 6 | 89ef0d0e66dc96cacaae6be7aacdaa884e8e66a8 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_pericyte_(14)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.54e-05 | 189 | 136 | 6 | 9c2492c38f27e4c699b40680652e4c64911cce52 | |
| ToppCell | (1)_Osterolineage_cells-(10)_OLC-1|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 2.54e-05 | 189 | 136 | 6 | 46c5b975fb9d33017f2d9b7770d45a8bdf95baa2 | |
| ToppCell | facs-Heart-LA/RA|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.54e-05 | 189 | 136 | 6 | efa913d9c16fc32166b484d92b6449e8a0c59e03 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 2.54e-05 | 189 | 136 | 6 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 2.61e-05 | 190 | 136 | 6 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | Control-Lymphoid-NK|Lymphoid / Disease state, Lineage and Cell class | 2.61e-05 | 190 | 136 | 6 | 1584c68b58c7f406d9b0e8451beea3e6f8980c56 | |
| ToppCell | COVID-19-kidney-NK|kidney / Disease (COVID-19 only), tissue and cell type | 2.61e-05 | 190 | 136 | 6 | e3ca3c9fb9e27670a5dd128dd6564ff98a57159e | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.61e-05 | 190 | 136 | 6 | 4f775ee24b14733f06ae40b45f2dc1a0f0df0705 | |
| ToppCell | Control-Lymphoid-NK|Control / Disease state, Lineage and Cell class | 2.61e-05 | 190 | 136 | 6 | f7bd8521a40ac30a64dc439f17e2f6c7d021ef65 | |
| ToppCell | droplet-Heart-4Chambers-21m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.69e-05 | 191 | 136 | 6 | c172c9e17b893b290e4aa8af5e5e4cd3e4818372 | |
| ToppCell | droplet-Heart-4Chambers-21m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.69e-05 | 191 | 136 | 6 | 715f5b449b8e075959c05a5b38389df319663164 | |
| ToppCell | IPF-Lymphoid-NK|World / Disease state, Lineage and Cell class | 2.69e-05 | 191 | 136 | 6 | f206159b9d5e84cf14a65bfdc008895cec5a8081 | |
| ToppCell | droplet-Heart-nan-18m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.77e-05 | 192 | 136 | 6 | 0bf99e029a06151092db1e8a0dcb45f4e688e771 | |
| ToppCell | Mesenchymal_cells-Ng2+_MSCs|World / Lineage and Cell class | 2.77e-05 | 192 | 136 | 6 | 0703b8ec6960ff975ee5a2737054db67cab016b5 | |
| ToppCell | droplet-Heart-nan-18m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.77e-05 | 192 | 136 | 6 | d766221acfce30cbf2c60b3ae40f6744968b952c | |
| ToppCell | wk_15-18-Endothelial-Lymph_endothelial-Lymphatic_endo|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.94e-05 | 194 | 136 | 6 | bc03d0f8dca9f4ba10db2f2274293f8b119e8951 | |
| ToppCell | COVID-19-lung-NK/NKT|lung / Disease (COVID-19 only), tissue and cell type | 3.02e-05 | 195 | 136 | 6 | 3ab941a369e3815f338890b116dc77aefa054098 | |
| ToppCell | metastatic_Lymph_Node-T/NK_cells-NK|metastatic_Lymph_Node / Location, Cell class and cell subclass | 3.11e-05 | 196 | 136 | 6 | f69f53e2ac1818b4ad0161b0bd70655e98ef65f0 | |
| ToppCell | droplet-Heart-HEART-1m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.11e-05 | 196 | 136 | 6 | a582130862bee76c0385156a333bfdfc75cf218b | |
| ToppCell | droplet-Heart-HEART-1m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.11e-05 | 196 | 136 | 6 | fba52a4b82086dbae9a55038bf44c4539be926f5 | |
| ToppCell | wk_15-18-Endothelial-Lymph_endothelial|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.11e-05 | 196 | 136 | 6 | ff627244d7f5fd6a2ec009dae32d3509f0e2d95e | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c05-ZNF683|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.20e-05 | 197 | 136 | 6 | ff34be81ee77efe60618641fa7c1084442b991d7 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c07-TYROBP|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.20e-05 | 197 | 136 | 6 | 2abe27f6722fa0dab801bca4cd19e34c1fb4173e | |
| ToppCell | 18-Distal-Endothelial-Endothelial|Distal / Age, Tissue, Lineage and Cell class | 3.29e-05 | 198 | 136 | 6 | efd3af3c0b4ab29605331ecdcb7a52cba38e6028 | |
| ToppCell | 18-Distal-Endothelial|Distal / Age, Tissue, Lineage and Cell class | 3.29e-05 | 198 | 136 | 6 | ee657a84928d54eb7a9a66c7acb19a7c119d6423 | |
| ToppCell | severe_COVID-19-NK|World / disease group, cell group and cell class (v2) | 3.29e-05 | 198 | 136 | 6 | 36b1370ef68c4bbe0268933a6ef5e6022d992bdf | |
| ToppCell | VE-CD8-CD8_1|VE / Condition, Cell_class and T cell subcluster | 3.29e-05 | 198 | 136 | 6 | 9747a486fddec917a3753651de0b2079ac2385ee | |
| ToppCell | distal-2-Hematologic-Natural_Killer|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.39e-05 | 199 | 136 | 6 | 77cc79c612c56022b37c8f690363c9ac8776e9cf | |
| ToppCell | medial-Hematologic-Natural_Killer|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.39e-05 | 199 | 136 | 6 | 4a75ef6a3b7b5d779a08d039a79322cd60b4ef65 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.39e-05 | 199 | 136 | 6 | b03539908131308d7bf5036e78c4c840a6a79a17 | |
| ToppCell | medial-2-Hematologic-Natural_Killer|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.39e-05 | 199 | 136 | 6 | 52338b8970fba0b32578748ba0bec0b344171ca6 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-NK_cell-NK|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.39e-05 | 199 | 136 | 6 | 4820f5bcd7bc34c2ebf6a3422cc8eb383a3b5a4e | |
| ToppCell | medial-Hematologic-Natural_Killer-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.39e-05 | 199 | 136 | 6 | dfcc4976688c7e6df5e41ae77436710075f1f779 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-NK_cell|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.39e-05 | 199 | 136 | 6 | eb05ccae5187e4701bbbe6d714a6d2808fbcf306 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-NK_cell|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.39e-05 | 199 | 136 | 6 | 10c8729b779073c3bf808e85958d59147f0be5c5 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-NK_cell-NK-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.39e-05 | 199 | 136 | 6 | 867fd292f3879982422e840e087bfdb3b21a8715 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.39e-05 | 199 | 136 | 6 | 7d071c88a003babf6dbdb84dde561fc03c92f375 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-NK_cell-NK-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.39e-05 | 199 | 136 | 6 | 5e9fe852a70546c9d235414a2c26ca3e67ba6eb9 | |
| ToppCell | Control-Lymphoid_T/NK-NK|Control / Disease group, lineage and cell class | 3.39e-05 | 199 | 136 | 6 | 94b2693a8378b9b2c58c6aebb2c6658d75b2e3de | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-NK_cell-NK|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.39e-05 | 199 | 136 | 6 | d2c9fb69e5ef75778a1652da293fcf8cfa7ecfcc | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW26|fetalBrain_Zhong_nature / Sample Type, Dataset, Time_group, and Cell type. | 3.48e-05 | 200 | 136 | 6 | 61d7dd0a78942b069c3f5e75044368dc00e6e8e6 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW08-Stem_cells|GW08 / Sample Type, Dataset, Time_group, and Cell type. | 3.48e-05 | 200 | 136 | 6 | 691b3edf7d8449556e8bf611662eb85772959f0f | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW08-Stem_cells-Stem_cells|GW08 / Sample Type, Dataset, Time_group, and Cell type. | 3.48e-05 | 200 | 136 | 6 | 36a110aa91a791fdf1142e7869e8aa0d342402d0 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW08-Stem_cells-Neuroepithelial_cell|GW08 / Sample Type, Dataset, Time_group, and Cell type. | 3.48e-05 | 200 | 136 | 6 | 4e077aa7faddcebdfc54667f8b3990704441005b | |
| ToppCell | distal-Hematologic-Natural_Killer|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.48e-05 | 200 | 136 | 6 | 33947befb9d32ec00f9f3e7eedaac478dcd63b20 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW08-Stem_cells|GW08 / Sample Type, Dataset, Time_group, and Cell type. | 3.48e-05 | 200 | 136 | 6 | d17ba4239e1fd702a3d757687110f0f2c6f91ef7 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type. | 3.48e-05 | 200 | 136 | 6 | 5c7263c862093ad9dbc81d06b16b6f74e8a6b634 | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_STALK-Flt1_1|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 5.52e-05 | 133 | 136 | 5 | bc29a2faa151b0e48c1c7e3f016cccc49f9a15eb | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Mucinous_Carcinoma|TCGA-Breast / Sample_Type by Project: Shred V9 | 7.05e-05 | 140 | 136 | 5 | 82b150e9e9962460a5cd6bef7ee04f28f5c05d1a | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Mucinous_Carcinoma-1|TCGA-Breast / Sample_Type by Project: Shred V9 | 9.46e-05 | 149 | 136 | 5 | 649eb3441fa859591ea85f1ed5fcf08af272a32b | |
| ToppCell | 343B-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.01e-04 | 151 | 136 | 5 | 78475027bba9e3026e42493fec8ea630972353bb | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Myeloid-Myeloid_Dendritic_Type_1|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-04 | 152 | 136 | 5 | 87a7116d0064a6051bdf28ce1e48bfc168273e66 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-H-|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.04e-04 | 152 | 136 | 5 | dbfb4d4de36ef9f5c7da1950baa915b12788685e | |
| ToppCell | 368C-Fibroblasts-Fibroblast-H|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.04e-04 | 152 | 136 | 5 | 9f3682da00fd627e80aa820ecc6f5fed23b9738a | |
| ToppCell | 367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1.5|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.10e-04 | 154 | 136 | 5 | ea5d0da5dd8ccfc19969aec35f044db77d589f54 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_Invariant-Inducer-like-ILC3|bone_marrow / Manually curated celltypes from each tissue | 1.14e-04 | 155 | 136 | 5 | 83430a64c2cb5ad29caa3dacba76c28dd204ac40 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Myeloid-myeloid_leukocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-04 | 158 | 136 | 5 | 91d265e95156f16459924d3e4dd11c180e164eee | |
| ToppCell | Posterior_cortex-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Car4_(Car4)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.28e-04 | 84 | 136 | 4 | f7ce09c6fb2795b7aecabce00cb9830b3c1a7d0e | |
| ToppCell | Posterior_cortex-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Car4_(Car4)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.28e-04 | 84 | 136 | 4 | 5d5e519a6652029b9f5275c8e648bbb123fd07b9 | |
| ToppCell | Posterior_cortex-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Car4_(Car4)--|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.28e-04 | 84 | 136 | 4 | 2b477de422a9f6a8474cba05094577b88236a4f0 | |
| Drug | Gvapspat amide | 2.02e-08 | 15 | 136 | 5 | CID000125015 | |
| Drug | SK&F 82958 | 7.68e-08 | 19 | 136 | 5 | ctd:C071262 | |
| Drug | Laevuflex | ACACA FPR1 SREBF1 ACE ADCY1 ADCY2 ADCY5 PKM PYGB PYGM HERC1 UROD | 9.05e-08 | 272 | 136 | 12 | CID000003426 |
| Drug | AC1Q6RZ4 | 7.62e-07 | 123 | 136 | 8 | CID000000719 | |
| Drug | Mem-CC | 8.30e-07 | 4 | 136 | 3 | CID003081269 | |
| Drug | NSC406942 | MAN2B2 MYO1C FPR1 CPT1B ADCY1 ADCY2 ADCY5 RYR1 RYR2 ITPR1 PYGB PYGM BOP1 UROD DYNC1H1 | 1.51e-06 | 565 | 136 | 15 | CID000001115 |
| Drug | Kynurenine, 3-hydroxy (R,S) [2147-61-7]; Down 200; 17.8uM; MCF7; HT_HG-U133A | 2.59e-06 | 194 | 136 | 9 | 5641_DN | |
| Drug | Betazole hydrochloride; Up 200; 27uM; PC3; HT_HG-U133A | 2.59e-06 | 194 | 136 | 9 | 1812_UP | |
| Drug | Delcorine; Down 200; 8.4uM; PC3; HT_HG-U133A | 2.59e-06 | 194 | 136 | 9 | 4275_DN | |
| Drug | Scopolamin-N-oxide hydrobromide [6106-81-6]; Up 200; 10uM; PC3; HT_HG-U133A | 3.07e-06 | 198 | 136 | 9 | 2099_UP | |
| Drug | tungstate | 3.92e-06 | 108 | 136 | 7 | CID000001152 | |
| Drug | cobalt-60 | MAN2B2 DPP3 CPT1B ADCY1 ADCY2 ADCY5 RYR1 RYR2 ITPR1 GGT5 PKM UROD | 4.06e-06 | 390 | 136 | 12 | CID000061492 |
| Drug | [[(2R,3S,4R)-5-(2-amino-6-oxo-3H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R,5R)-3,4,5-trihydroxyoxolan-2-yl]methyl hydrogen phosphate | 7.17e-06 | 7 | 136 | 3 | CID009547999 | |
| Drug | Br2BAPTA | 7.17e-06 | 7 | 136 | 3 | CID003081001 | |
| Drug | D-myo-inositol-1,4,5-triphosphate | IP6K3 FPR1 ACE BCR ADCY1 ADCY2 ADCY5 ZAP70 RYR1 RYR2 ITPR1 MST1R PYGB PYGM | 8.05e-06 | 568 | 136 | 14 | CID000000806 |
| Drug | 1 Em | 1.05e-05 | 83 | 136 | 6 | CID000446621 | |
| Drug | amorphin | 1.14e-05 | 8 | 136 | 3 | CID000122792 | |
| Drug | trimetoquinol | 1.18e-05 | 24 | 136 | 4 | CID000005581 | |
| Drug | T0702 | 1.40e-05 | 25 | 136 | 4 | CID000005908 | |
| Drug | N-nitrosomorpholine | 1.47e-05 | 52 | 136 | 5 | CID000006046 | |
| Drug | indapamide | 1.61e-05 | 53 | 136 | 5 | CID000003702 | |
| Drug | SM-10906 | 1.92e-05 | 27 | 136 | 4 | CID006442261 | |
| Drug | baclofen | 2.00e-05 | 191 | 136 | 8 | CID000002284 | |
| Drug | NSC759576 | 2.00e-05 | 191 | 136 | 8 | CID000003075 | |
| Drug | DNA-PK Inhibitor III; Up 200; 1uM; PC3; HT_HG-U133A | 2.07e-05 | 192 | 136 | 8 | 7548_UP | |
| Drug | desacetylnantradol | 2.23e-05 | 28 | 136 | 4 | CID000125211 | |
| Drug | Moricizine hydrochloride [31883-05-3]; Up 200; 8.6uM; HL60; HT_HG-U133A | 2.23e-05 | 194 | 136 | 8 | 2959_UP | |
| Drug | quin2 | 2.29e-05 | 95 | 136 | 6 | CID000104841 | |
| Drug | 2-propylpentanoic acid; Down 200; 1000uM; MCF7; HT_HG-U133A | 2.40e-05 | 196 | 136 | 8 | 5569_DN | |
| Drug | PCB 95 | 2.43e-05 | 10 | 136 | 3 | CID000038012 | |
| Drug | 2',5'-dd3'-FSBA | 2.43e-05 | 10 | 136 | 3 | CID003081206 | |
| Drug | NC-5Z | 2.43e-05 | 10 | 136 | 3 | CID003035914 | |
| Drug | Alfadolone acetate [23930-37-2]; Down 200; 10.2uM; HL60; HT_HG-U133A | 2.49e-05 | 197 | 136 | 8 | 3127_DN | |
| Drug | Etodolac [41340-25-4]; Up 200; 14uM; PC3; HT_HG-U133A | 2.49e-05 | 197 | 136 | 8 | 2091_UP | |
| Drug | Arcaine sulfate [14923-17-2]; Down 200; 14.8uM; MCF7; HT_HG-U133A | 2.49e-05 | 197 | 136 | 8 | 4974_DN | |
| Drug | motapizone | 2.58e-05 | 29 | 136 | 4 | CID000065819 | |
| Drug | Pridinol methanesulfonate salt [6856-31-1]; Up 200; 10.2uM; HL60; HT_HG-U133A | 2.58e-05 | 198 | 136 | 8 | 2715_UP | |
| Drug | Trichlorfon [52-68-6]; Up 200; 15.6uM; PC3; HT_HG-U133A | 2.68e-05 | 199 | 136 | 8 | 1797_UP | |
| Drug | Benoxinate hydrochloride [5987-82-6]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 2.68e-05 | 199 | 136 | 8 | 4115_UP | |
| Drug | myo-inositol | ACACA IP6K3 FPR1 BCR TRRAP ADCY1 ADCY2 ADCY5 ZAP70 RYR1 RYR2 ITPR1 SERPINA4 TAF5 GNAZ THAP12 | 2.82e-05 | 811 | 136 | 16 | CID000000892 |
| Drug | epicholesterol | ACACA SREBF1 ACE LYST ABCA7 ADCY1 PTGIS ADCY2 ABCA9 ADCY5 GGT5 VPS52 LRP2 PML | 2.83e-05 | 636 | 136 | 14 | CID000000304 |
| Drug | GI-3 | 2.95e-05 | 147 | 136 | 7 | CID011957433 | |
| Drug | AC1N2DGT | 2.96e-05 | 30 | 136 | 4 | CID004045015 | |
| Drug | AC1L40QM | 3.32e-05 | 11 | 136 | 3 | CID000099213 | |
| Drug | B-Mlvp | 3.32e-05 | 11 | 136 | 3 | CID000195648 | |
| Drug | 9 Da | 3.32e-05 | 11 | 136 | 3 | CID005287565 | |
| Drug | AC1NY9KD | 3.32e-05 | 11 | 136 | 3 | CID005771741 | |
| Drug | R 478 | 3.32e-05 | 11 | 136 | 3 | CID000084223 | |
| Drug | 8-amino-cADPR | 3.32e-05 | 11 | 136 | 3 | CID003081323 | |
| Drug | 7-tricosene | 3.54e-05 | 2 | 136 | 2 | CID006365493 | |
| Drug | 1-methyladenosine | 4.36e-05 | 33 | 136 | 4 | CID000027476 | |
| Drug | phenylurethane | 4.41e-05 | 12 | 136 | 3 | CID000007591 | |
| Drug | phytate | 4.87e-05 | 159 | 136 | 7 | CID000000890 | |
| Drug | pyruvic acid | 4.97e-05 | 424 | 136 | 11 | CID000001060 | |
| Drug | AC1L9HHR | 5.46e-05 | 354 | 136 | 10 | CID000445141 | |
| Drug | U46619 | 5.56e-05 | 285 | 136 | 9 | CID000005618 | |
| Drug | Arginylarginine | 5.71e-05 | 163 | 136 | 7 | CID000151956 | |
| Drug | FCE 23884 | 5.71e-05 | 13 | 136 | 3 | CID000065898 | |
| Drug | AC1L2AC7 | 5.84e-05 | 69 | 136 | 5 | CID000068733 | |
| Drug | chlorthalidone | 6.18e-05 | 36 | 136 | 4 | CID000002732 | |
| Drug | felodipine | 7.17e-05 | 169 | 136 | 7 | CID000003333 | |
| Drug | trimetaphosphate | 7.23e-05 | 14 | 136 | 3 | CID000000510 | |
| Drug | CAS 298-57-7 | 7.66e-05 | 73 | 136 | 5 | CID000002761 | |
| Drug | manganese | ADCY1 ADCY2 ADCY5 ZAP70 RYR1 RYR2 ITPR1 MGAT2 PAPOLA PKM PYGB PYGM UROD CHPF PML | 7.93e-05 | 791 | 136 | 15 | CID000023930 |
| Drug | Ts-I | 8.72e-05 | 75 | 136 | 5 | CID000445278 | |
| Drug | BMY 42393 | 9.00e-05 | 15 | 136 | 3 | CID000131961 | |
| Drug | spinorphin | 9.00e-05 | 15 | 136 | 3 | CID003081832 | |
| Drug | NSC236997 | CPT1B ACE LYST ADCY1 ADCY2 ADCY5 RYR2 PKM PYGB PYGM TNKS2 XRCC6 | 9.73e-05 | 539 | 136 | 12 | CID000005300 |
| Drug | AC1OAGFB | MYO1C FPR1 TRRAP ADCY1 ADCY2 ADCY5 ZAP70 ITPR1 SPTBN4 SERPINA4 HERC1 GNAZ | 9.73e-05 | 539 | 136 | 12 | CID006857345 |
| Drug | Flurandrenolide [1524-88-5]; Up 200; 9.2uM; HL60; HT_HG-U133A | 1.03e-04 | 179 | 136 | 7 | 2184_UP | |
| Drug | 3,5-dimethylphenyl isocyanate | 1.06e-04 | 3 | 136 | 2 | CID000521488 | |
| Drug | N-piperidinyl-(8-chloro-1-(2,4-dichlorophenyl)-1,4,5,6-tetrahydrobenzo(6,7)cyclohepta(1,2-c)pyrazole-3-carboxamide) | 1.06e-04 | 3 | 136 | 2 | ctd:C475771 | |
| Drug | 5'-deoxy-5'-fluoro-5'-(methylthio)adenosine | 1.06e-04 | 3 | 136 | 2 | CID000147839 | |
| Drug | cis-diammineplatinum(II | 1.06e-04 | 3 | 136 | 2 | CID000159790 | |
| Drug | 2-hydroxyheptanoic acid | 1.06e-04 | 3 | 136 | 2 | CID002750949 | |
| Drug | 8N3-cADPR | 1.06e-04 | 3 | 136 | 2 | CID000127713 | |
| Drug | NSC758405 | 1.06e-04 | 3 | 136 | 2 | CID000003201 | |
| Drug | aminodantrolene | 1.06e-04 | 3 | 136 | 2 | CID009570289 | |
| Drug | 3,5-dinitrophenyl phosphate | 1.06e-04 | 3 | 136 | 2 | CID000151920 | |
| Drug | pyridoxal phosphoglucose | 1.06e-04 | 3 | 136 | 2 | CID000196007 | |
| Drug | 5-ethyl-4-hydroxy-2-methyl-3(2H)-furanone | 1.06e-04 | 3 | 136 | 2 | CID000093111 | |
| Drug | adenosine-5'-chloromethylphosphonate | 1.06e-04 | 3 | 136 | 2 | CID000191554 | |
| Drug | hydan | 1.06e-04 | 3 | 136 | 2 | CID000008360 | |
| Drug | EHMF | 1.06e-04 | 3 | 136 | 2 | CID000033931 | |
| Drug | 2-hydroxycarbazole | 1.06e-04 | 3 | 136 | 2 | CID000093551 | |
| Drug | pyridoxal 5'-methylenephosphonate | 1.06e-04 | 3 | 136 | 2 | CID003082249 | |
| Drug | Plp 5'-mpa | 1.06e-04 | 3 | 136 | 2 | CID003082151 | |
| Drug | glucose-1,2-cyclic phosphate | 1.06e-04 | 3 | 136 | 2 | CID000191723 | |
| Drug | 3'-FFdUrd | 1.06e-04 | 3 | 136 | 2 | CID000072260 | |
| Drug | 2',3',4',5,5'-pentachloro-2-biphenylol | 1.06e-04 | 3 | 136 | 2 | CID000119518 | |
| Drug | AC1L8XK3 | 1.06e-04 | 3 | 136 | 2 | CID000409735 | |
| Drug | Ryanodyl 3-(pyridine-3-carboxylate | 1.06e-04 | 3 | 136 | 2 | CID005748312 | |
| Drug | N-acetyl-N'-beta-D-glucopyranosyl urea | 1.06e-04 | 3 | 136 | 2 | CID000446801 | |
| Drug | riboflavin tetraacetate | 1.06e-04 | 3 | 136 | 2 | CID000094186 | |
| Drug | 2,5-dimethyl-3-furanone | 1.06e-04 | 3 | 136 | 2 | CID000085730 | |
| Drug | 3,5-dinitrophenol | 1.06e-04 | 3 | 136 | 2 | CID000011459 | |
| Drug | aluminum | 1.22e-04 | 184 | 136 | 7 | CID000104727 | |
| Drug | 2',3'-dideoxyadenosine | 1.33e-04 | 82 | 136 | 5 | CID000020039 | |
| Drug | mannosylamine | 1.33e-04 | 17 | 136 | 3 | CID000192844 | |
| Drug | escina | 1.37e-04 | 44 | 136 | 4 | CID006433489 | |
| Disease | sphingomyelin 14:0 measurement | 8.44e-07 | 17 | 131 | 4 | EFO_0010390 | |
| Disease | Glycogen Storage Disease Type V | 1.96e-05 | 2 | 131 | 2 | C0017924 | |
| Disease | Multiminicore myopathy | 1.96e-05 | 2 | 131 | 2 | cv:C0270962 | |
| Disease | congenital myopathy 1A (implicated_via_orthology) | 5.85e-05 | 3 | 131 | 2 | DOID:3529 (implicated_via_orthology) | |
| Disease | malignant hyperthermia (implicated_via_orthology) | 5.85e-05 | 3 | 131 | 2 | DOID:8545 (implicated_via_orthology) | |
| Disease | lymphocyte count | MYO1G PDE4D ACACA FPR1 SREBF1 P2RY8 RAB40A TDRD1 BCR LYST ADCY5 ITPR1 GGT5 MST1R THADA PSME4 SPHK1 DNPEP | 8.59e-05 | 1464 | 131 | 18 | EFO_0004587 |
| Disease | Small cell carcinoma of lung | 9.88e-05 | 54 | 131 | 4 | C0149925 | |
| Disease | Rare disease with malignant hyperthermia | 1.17e-04 | 4 | 131 | 2 | cv:C5681128 | |
| Disease | atopy | 1.94e-04 | 5 | 131 | 2 | EFO_0002686 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 2.43e-04 | 195 | 131 | 6 | DOID:1574 (implicated_via_orthology) | |
| Disease | Congenital myopathy with fiber type disproportion | 2.90e-04 | 6 | 131 | 2 | cv:C0546264 | |
| Disease | familial Mediterranean fever (is_implicated_in) | 6.90e-04 | 9 | 131 | 2 | DOID:2987 (is_implicated_in) | |
| Disease | cholestasis (implicated_via_orthology) | 6.90e-04 | 9 | 131 | 2 | DOID:13580 (implicated_via_orthology) | |
| Disease | Congenital muscular dystrophy | 1.25e-03 | 12 | 131 | 2 | cv:C0699743 | |
| Disease | Congenital myopathy (disorder) | 1.25e-03 | 12 | 131 | 2 | C0270960 | |
| Disease | Autosomal Dominant Myotubular Myopathy | 1.48e-03 | 13 | 131 | 2 | C3661489 | |
| Disease | Centronuclear myopathy | 1.48e-03 | 13 | 131 | 2 | C0175709 | |
| Disease | X-linked centronuclear myopathy | 1.48e-03 | 13 | 131 | 2 | C0410203 | |
| Disease | Myopathy, Centronuclear, 1 | 1.48e-03 | 13 | 131 | 2 | C4551952 | |
| Disease | leukemia (is_implicated_in) | 1.48e-03 | 13 | 131 | 2 | DOID:1240 (is_implicated_in) | |
| Disease | Congenital Structural Myopathy | 1.48e-03 | 13 | 131 | 2 | C0752282 | |
| Disease | glucose measurement | 1.58e-03 | 380 | 131 | 7 | EFO_0004468 | |
| Disease | Myopathy, Centronuclear, Autosomal Dominant | 1.72e-03 | 14 | 131 | 2 | C1834558 | |
| Disease | Tubular Aggregate Myopathy | 1.72e-03 | 14 | 131 | 2 | C0410207 | |
| Disease | Liver carcinoma | 1.97e-03 | 507 | 131 | 8 | C2239176 | |
| Disease | Autosomal Recessive Centronuclear Myopathy | 1.98e-03 | 15 | 131 | 2 | C3645536 | |
| Disease | YKL40 measurement | 1.98e-03 | 15 | 131 | 2 | EFO_0004869 | |
| Disease | phosphorus measurement | 2.25e-03 | 16 | 131 | 2 | EFO_0004861 | |
| Disease | Congenital Fiber Type Disproportion | 2.86e-03 | 18 | 131 | 2 | C0546264 | |
| Disease | amino acid measurement | 3.34e-03 | 678 | 131 | 9 | EFO_0005134 | |
| Disease | gestational age | 3.39e-03 | 138 | 131 | 4 | EFO_0005112 | |
| Disease | congenital heart disease (implicated_via_orthology) | 3.62e-03 | 69 | 131 | 3 | DOID:1682 (implicated_via_orthology) | |
| Disease | Arthrogryposis | 3.89e-03 | 21 | 131 | 2 | C0003886 | |
| Disease | nephrosis (biomarker_via_orthology) | 4.26e-03 | 22 | 131 | 2 | DOID:2527 (biomarker_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| IIPLNRIYHLNRNID | 356 | Q9BXT4 | |
| QVQRVAFHPARPFLL | 581 | Q14137 | |
| LVRLVHQERTLAFPL | 96 | Q9UNN8 | |
| LLPSRFREFLHQLQE | 146 | Q5SZB4 | |
| PFHAVAECRNRLLQA | 41 | Q9ULA0 | |
| QLEPLYLNLHAFVRR | 246 | P12821 | |
| HPLLQDALRISQNFL | 671 | P11274 | |
| LHAEILRLFPQAAQQ | 1531 | Q8IUA7 | |
| NLIFPRRDLISIEHQ | 2221 | Q7Z2Y8 | |
| RHLEPALAFQLELNR | 1371 | Q13085 | |
| ILEALQRVFPHAEFR | 716 | Q6PL18 | |
| ELQAYNRRLLHNILP | 1031 | O95622 | |
| NRRLLHNILPKDVAA | 1036 | O95622 | |
| VVPLDRQFLIHELNA | 81 | Q96NB1 | |
| AAQRPEAQAFHRLLA | 521 | Q9NUG4 | |
| FVNRASNAILRAHLP | 1486 | Q8IZY2 | |
| NRLHLAFKRQVPREQ | 126 | Q8WXH6 | |
| NRLHLAFKRQVPREQ | 126 | P0C0E4 | |
| ALANALRRHLPFLEA | 146 | Q92932 | |
| APNNFVLLAHIVSRL | 251 | Q86VZ1 | |
| PALAFLRENLRALHI | 486 | Q8IWT6 | |
| PALQRAQLRLDFIHA | 6 | Q86VD1 | |
| ILHLVPNIDNFRLTL | 211 | Q9NRJ5 | |
| LYQRPQASHQLLRIL | 181 | P06132 | |
| RLREPQLLEAIAHFL | 251 | Q14296 | |
| VSLDRIQLFLDLPNH | 566 | Q5T3U5 | |
| RATAQELLDHPFLLQ | 646 | Q9NQU5 | |
| RNQFPEILRRAAAHL | 526 | Q9HCI5 | |
| PEILRRASAHLDQVF | 126 | Q8TD90 | |
| LLRFNQAILVSRHDP | 161 | Q643R3 | |
| VVQVHNRPEYLRLLL | 121 | Q10469 | |
| ILNVFFQRDPSLLLH | 736 | Q9Y4C4 | |
| PILRFLQLLCENHNR | 1976 | Q14643 | |
| DPRNLLVAFRIVHDL | 186 | Q96T76 | |
| LARSPFLVLHVRRNN | 696 | Q15034 | |
| RRLPAFANLQEALLE | 1851 | Q6ZU64 | |
| AAALANPHDRVVALR | 3161 | Q15751 | |
| AFRLLHALQDLILPE | 196 | Q9UBM4 | |
| LHVFRIAELSGNRPL | 406 | Q08499 | |
| LARFLNPDEVHAILR | 56 | Q9H4H8 | |
| LFRAQDPDQLRQHAL | 66 | Q9NY33 | |
| HLQLFEELRRLAPIT | 391 | P14618 | |
| LHFTPRIQRLNELEA | 81 | Q9UGL1 | |
| FPDNDLLRHLRLVTQ | 791 | Q9UGL1 | |
| LRDDQPFLITVRQHI | 1741 | P98164 | |
| PENKRHRFLLLENVV | 191 | Q96PC2 | |
| ISFLQLHPRIDARRA | 391 | Q5XG87 | |
| LPVLVRFVDESHNLR | 276 | O43422 | |
| FHRSPQLLLELDNVI | 391 | O43422 | |
| VLSDLPRFQAARQAL | 31 | Q6MZQ0 | |
| AAPVRFLRELQHQEV | 3976 | Q5VST9 | |
| LHLVPNIDNFRLTLR | 211 | P51003 | |
| EFSRLLRAVHQIPGL | 41 | Q9NPB6 | |
| ADPHAQLLQRRLDFL | 406 | Q86VR8 | |
| IQRAFDIRSINLHFP | 301 | P20848 | |
| LNRVLLENVLPAHVA | 851 | Q08462 | |
| LDNRRILFNLLPAHV | 831 | Q08828 | |
| RALAALRIDFHNPDR | 86 | P19086 | |
| PRILLANRNEVFHRE | 81 | Q92947 | |
| QFLSRRNEIPLIHFN | 156 | Q9GZV9 | |
| RPQIERAIHEFLAAQ | 146 | Q96IK1 | |
| LLARLLEDQQVHFTP | 86 | P26441 | |
| FDLRAAIAAPILHVN | 511 | P36269 | |
| AALRRAAHVLDIFPI | 281 | Q9Y2A9 | |
| RNDPRLFILIHRQAL | 3331 | Q99698 | |
| LNIQVQELFLHPVLR | 181 | Q96P31 | |
| QRSALALQHRPVVLF | 836 | Q9Y2E5 | |
| LDHVLRIDRIFRQPQ | 2916 | Q14204 | |
| AIHRLLLIQAFRPDR | 3986 | Q14204 | |
| AFPATRNVLRQLHEL | 651 | Q8N766 | |
| RNVLRQLHELAPSIF | 656 | Q8N766 | |
| APRVLIALLARNAAH | 51 | Q8NBJ5 | |
| ANAARHVAPEIRELL | 571 | Q6NUJ5 | |
| HLLRRLVFDVPILNE | 2621 | P21817 | |
| QHLLRRLVFDVPLLN | 2586 | Q92736 | |
| ELHLNNNLLRVLPFE | 101 | Q9ULM6 | |
| PDAFVQIALQLAHFR | 566 | Q92523 | |
| ELRHLNLAFNNLPCI | 206 | Q86YC3 | |
| LPRLLVQALQAFRVA | 551 | P0CW18 | |
| LPALRQNRYLELHVV | 1211 | A6NKG5 | |
| PLRLADFGVLHRNEL | 431 | P26639 | |
| PHDRQTLLAVLQFLR | 91 | Q15542 | |
| PQVHALNILRALFRD | 1206 | Q6YHU6 | |
| VLLERLRHPNVLQLY | 201 | Q504Y2 | |
| RFVPLTHLDLRGNQL | 181 | Q9H5Y7 | |
| RVPEGQHLFENLLRL | 851 | Q6ZMZ3 | |
| PQLDIQVLHDLRQRF | 6 | Q8N5C8 | |
| LANNHLETLPRFLFR | 131 | Q8N135 | |
| RGAHVFQPLLIARDQ | 451 | Q8N135 | |
| LIHRILTLFPNAIAR | 6 | Q96DL1 | |
| FFRDRQELLQHSLPL | 206 | A1L390 | |
| EPSVRQLALLHFRNA | 141 | P85299 | |
| ADVFHTFRQLDRLLP | 201 | Q16647 | |
| QTNRHILRFNRPFLV | 391 | P29622 | |
| PRAEARLLALHNVSF | 791 | P29590 | |
| VQIQLQRDALRHFAP | 116 | Q9H7J1 | |
| QDFRERLIHALPASL | 306 | P21462 | |
| IRRFLNLPQHERDVI | 541 | Q9UPW6 | |
| AIANAFRRILLAEVP | 71 | O15160 | |
| LPEFNRLHLQRLVSN | 351 | Q5JPH6 | |
| LLVAQRDRASRIFPH | 321 | Q8TE77 | |
| DPLAQVTQLFREHLL | 796 | P36956 | |
| AAIRASQPRLLFQIF | 206 | Q9UM73 | |
| HPFAFRILRNRQEVA | 476 | Q8TED9 | |
| LLLYEPRQAQRVAHA | 546 | Q8IZ52 | |
| VRFPNDVLFLDHIRQ | 26 | Q86WC6 | |
| ERLFSNIPEIAQLHR | 381 | O94827 | |
| QLRALPARAELINIH | 696 | Q8N1B4 | |
| PVLQQHFRNLEALAL | 481 | P12956 | |
| NFVHRDLAARNVLLV | 456 | P43403 | |
| PQRLVSFRLIRDLHQ | 51 | Q8N511 | |
| ALAFVLQHLRRPVAL | 781 | Q9HC29 | |
| LQHLRRPVALQLDYN | 786 | Q9HC29 | |
| LLPRHLQIIYEINQR | 396 | P11217 | |
| HFEFNNLPAVRALRL | 311 | Q96PV0 | |
| LFRFVPLTHLDLRGN | 196 | O94991 | |
| QPRFHIVRANDILKL | 231 | Q13207 | |
| AFLQAPALARFLEHN | 86 | C9JR72 | |
| EALAVLARHRDPQLF | 581 | Q9P253 | |
| VRDFRLFVPNHRSLN | 326 | Q9NZV5 | |
| RYLRELPLLFHQNVL | 611 | Q6NUQ4 | |
| LLPRHLEIIYAINQR | 396 | P11216 | |
| DRHANTIRLFVLLPE | 816 | Q96K76 | |
| RVFRLPRELLEHQQS | 301 | O15015 | |
| ALLAERFPAQAARLH | 1046 | Q9H254 | |
| ERLRLNRNHLQLFPE | 106 | O94813 | |
| LPLRAIRFFVENLNH | 1181 | Q14997 | |
| VVNLLLRHGADPNAR | 106 | Q9H2K2 | |
| FPFIILDAINDRVRH | 1926 | P49750 | |
| VVLEPFRLQHNLAVS | 431 | Q8NF64 | |
| FLDRLAVIFRHTNPI | 611 | Q9Y5L0 | |
| KIIALPHDNRQVRLF | 421 | Q9Y2I8 | |
| RLFLDAVHQNRLPAA | 96 | Q86T82 | |
| LPALRSLQLNHALVR | 141 | P0DKB5 | |
| LQLFRSHVQPLLAEA | 31 | Q9NYA1 | |
| PSIRRNFHNLVLFID | 476 | Q9NYU1 | |
| FVAIRNRLHVLGPDL | 71 | Q04912 | |
| RDVLAANPNRFITLL | 1601 | Q9Y4A5 | |
| FFLHLVNLVERNRIG | 451 | Q92995 | |
| HVRTSFLLNLRRQLP | 811 | O00159 | |
| HLAELQRRFQAARQP | 751 | B0I1T2 | |
| AALDPLDLRRLQAVH | 476 | P54296 | |
| AFQRILIDHLRAPDT | 366 | Q96P71 |